Molecule Details
| InChIKey | XSVMFMHYUFZWBK-NSHDSACASA-N |
|---|---|
| Compound Name | Rivastigmine |
| Canonical SMILES | CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.87 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00989 |
|---|---|
| Drug Name | Rivastigmine |
| CAS Number | 123441-03-2 |
| Groups | approved investigational |
| ATC Codes | N06DA03 |
| Description | Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase. |
Categories: Acids, Acyclic Anti-Dementia Drugs Bradycardia-Causing Agents Carbamates Central Nervous System Agents Cholinergic Agents Cholinesterase Inhibitors Compounds used in a research, industrial, or household setting Enzyme Inhibitors Nervous System Neuroprotective Agents Neurotransmitter Agents Parasympathomemetic (Cholinergic) Agents Phenylcarbamates Protective Agents Psychoanaleptics
Cross-references: BindingDB: 11682 ChEBI: 8874 CHEMBL636 ChemSpider: 70377 Drugs Product Database (DPD): 11987 C11766 D03822 PharmGKB: PA451262 PubChem:77991 PubChem:46507452 RxCUI: 183379 Therapeutic Targets Database: DAP000149 Wikipedia: Rivastigmine ZINC: ZINC000000004413